Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:TSRO

Tesaro (TSRO) Stock Price, News & Analysis

Tesaro logo

About Tesaro Stock (NASDAQ:TSRO)

Advanced Chart

Key Stats

Today's Range
$74.94
$74.97
50-Day Range
N/A
52-Week Range
$23.41
$75.16
Volume
1.19 million shs
Average Volume
1.97 million shs
Market Capitalization
$4.13 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TSRO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Tesaro and its competitors with MarketBeat's FREE daily newsletter.

TSRO Stock News Headlines

Hedge Fund - Ivory Capital (Investment Mgmt)
Biopharma Cred. Regulatory News
[ATTENTION] This Crypto Rocket Is About Launch…
Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to two crypto experts, that moment is here. Their Crypto Code Workshop shows how to get positioned before altcoins take off, ride the wave, and lock in gains — with a free $10 Bitcoin bonus just for attending.
Gilbert H Kliman's Net Worth
Keval Desai's Net Worth
See More Headlines

TSRO Stock Analysis - Frequently Asked Questions

Tesaro, Inc. (NASDAQ:TSRO) announced its earnings results on Thursday, August, 2nd. The biopharmaceutical company reported ($3.04) earnings per share for the quarter, missing analysts' consensus estimates of ($2.66) by $0.38. Tesaro's revenue was up 94.2% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that Tesaro investors own include NVIDIA (NVDA), Bristol Myers Squibb (BMY), Clovis Oncology (CLVS), Netflix (NFLX), Meta Platforms (META), Alibaba Group (BABA) and AutoZone (AZO).

Company Calendar

Last Earnings
8/02/2018
Today
7/16/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:TSRO
CIK
1491576
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($9.17)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$496.12 million
Net Margins
-295.67%
Pretax Margin
N/A
Return on Equity
-1,209.72%
Return on Assets
-83.34%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.40
Quick Ratio
2.83

Sales & Book Value

Annual Sales
$223.33 million
Price / Sales
18.48
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$4.58 per share
Price / Book
16.37

Miscellaneous

Outstanding Shares
55,050,000
Free Float
N/A
Market Cap
$4.13 billion
Optionable
Optionable
Beta
0.38
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:TSRO) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners